Conditional hypoxia inducible factor-1α induction in embryonic pulmonary epithelium impairs maturation and augments lymphangiogenesis

Developmental Biology

Volumn 362, Issue 1, 2012, Pages 24-41

  Bridges, James P ^a   Lin, Sui ^a   Ikegami, Machiko ^a   Shannon, John M ^a  

^a CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

Author keywords

Development; Hypoxia; Lung; Lymphangiogenesis; Maturation; Notch

Indexed keywords

GLYCOGEN; HYPOXIA INDUCIBLE FACTOR 1ALPHA; LUNG SURFACTANT; NOTCH RECEPTOR;

ANIMAL CELL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BRANCHING MORPHOGENESIS; CONTROLLED STUDY; DEVELOPMENTAL DISORDER; EMBRYO; HISTOPATHOLOGY; LETHALITY; LUNG ALVEOLUS EPITHELIUM; LUNG BLOOD VESSEL; LUNG HEMORRHAGE; LUNG HYPOPLASIA; LYMPH VESSEL; LYMPHANGIOGENESIS; MOUSE; NECROSIS; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PULMONARY VASCULAR DISEASE; RESPIRATORY DISTRESS; STEM CELL; TRANSACTIVATION;

MUS MUSCULUS;

EID: 84855432325     PISSN: 00121606     EISSN: 1095564X     Source Type: Journal    
DOI: 10.1016/j.ydbio.2011.10.033     Document Type: Article

References (84)

1. Asikainen T.M., Ahmad A., Schneider B.K., White C.W. Effect of preterm birth on hypoxia-inducible factors and vascular endothelial growth factor in primate lungs. Pediatr. Pulmonol. 2005, 40:538-546.
2. Asikainen T.M., Chang L.Y., Coalson J.J., Schneider B.K., Waleh N.S., Ikegami M., Shannon J.M., Winter V.T., Grubb P., Clyman R.I., Yoder B.A., Crapo J.D., White C.W. Improved lung growth and function through hypoxia-inducible factor in primate chronic lung disease of prematurity. FASEB J. 2006, 20:1698-1700.
3. Asikainen T.M., Waleh N.S., Schneider B.K., Clyman R.I., White C.W. Enhancement of angiogenic effectors through hypoxia-inducible factor in preterm primate lung in vivo. Am. J. Physiol. Lung Cell. Mol. Physiol. 2006, 291:L588-L595.
4. Ban N., Matsumura Y., Sakai H., Takanezawa Y., Sasaki M., Arai H., Inagaki N. ABCA3 as a lipid transporter in pulmonary surfactant biogenesis. J. Biol. Chem. 2007, 282:9628-9634.
5. Baraldi E., Filippone M. Chronic lung disease after premature birth. N. Engl. J. Med. 2007, 357:1946-1955.
6. Bekeredjian R., Walton C.B., MacCannell K.A., Ecker J., Kruse F., Outten J.T., Sutcliffe D., Gerard R.D., Bruick R.K., Shohet R.V. Conditional HIF-1alpha expression produces a reversible cardiomyopathy. PLoS One 2010, 5:e11693.
7. Bligh E.G., Dyer W.J. A rapid method of total lipid extraction and purification. Can. J. Biochem. Physiol. 1959, 37:911-917.
8. Bridges J.P., Ikegami M., Brilli L.L., Chen X., Mason R.J., Shannon J.M. LPCAT1 regulates surfactant phospholipid synthesis and is required for transitioning to air breathing in mice. J. Clin. Invest. 2010, 120:1736-1748.
9. Bromley S.K., Thomas S.Y., Luster A.D. Chemokine receptor CCR7 guides T cell exit from peripheral tissues and entry into afferent lymphatics. Nat. Immunol. 2005, 6:895-901.
10. Bruick R.K., McKnight S.L. A conserved family of prolyl-4-hydroxylases that modify HIF. Science 2001, 294:1337-1340.
11. Cesarone C.F., Bolognesi C., Santi L. Improved microfluorometric DNA determination in biological material using 33258 Hoechst. Anal. Biochem. 1979, 100:188-197.
12. Chandel N.S. Mitochondrial regulation of oxygen sensing. Adv. Exp. Med. Biol. 2010, 661:339-354.
13. Clark J.C., Wert S.E., Bachurski C.J., Stahlman M.T., Stripp B.R., Weaver T.E., Whitsett J.A. Targeted disruption of the surfactant protein B gene disrupts surfactant homeostasis, causing respiratory failure in newborn mice. Proc. Natl. Acad. Sci. U. S. A. 1995, 92:7794-7798.
14. Compernolle V., Brusselmans K., Acker T., Hoet P., Tjwa M., Beck H., Plaisance S., Dor Y., Keshet E., Lupu F., Nemery B., Dewerchin M., Van Veldhoven P., Plate K., Moons L., Collen D., Carmeliet P. Loss of HIF-2alpha and inhibition of VEGF impair fetal lung maturation, whereas treatment with VEGF prevents fatal respiratory distress in premature mice. Nat. Med. 2002, 8:702-710.
15. Del Monte G., Grego-Bessa J., Gonzalez-Rajal A., Bolos V., De La Pompa J.L. Monitoring Notch1 activity in development: evidence for a feedback regulatory loop. Dev. Dyn. 2007, 236:2594-2614.
16. del Moral P.M., De Langhe S.P., Sala F.G., Veltmaat J.M., Tefft D., Wang K., Warburton D., Bellusci S. Differential role of FGF9 on epithelium and mesenchyme in mouse embryonic lung. Dev. Biol. 2006, 293:77-89.
17. Dioum E.M., Clarke S.L., Ding K., Repa J.J., Garcia J.A. HIF-2alpha-haploinsufficient mice have blunted retinal neovascularization due to impaired expression of a proangiogenic gene battery. Invest. Ophthalmol. Vis. Sci. 2008, 49:2714-2720.
18. El-Chemaly S., Malide D., Zudaire E., Ikeda Y., Weinberg B.A., Pacheco-Rodriguez G., Rosas I.O., Aparicio M., Ren P., MacDonald S.D., Wu H.P., Nathan S.D., Cuttitta F., McCoy J.P., Gochuico B.R., Moss J. Abnormal lymphangiogenesis in idiopathic pulmonary fibrosis with insights into cellular and molecular mechanisms. Proc. Natl. Acad. Sci. U. S. A. 2009, 106:3958-3963.
19. Elson D.A., Thurston G., Huang L.E., Ginzinger D.G., McDonald D.M., Johnson R.S., Arbeit J.M. Induction of hypervascularity without leakage or inflammation in transgenic mice overexpressing hypoxia-inducible factor-1alpha. Genes Dev. 2001, 15:2520-2532.
20. Ema M., Hirota K., Mimura J., Abe H., Yodoi J., Sogawa K., Poellinger L., Fujii-Kuriyama Y. Molecular mechanisms of transcription activation by HLF and HIF1alpha in response to hypoxia: their stabilization and redox signal-induced interaction with CBP/p300. EMBO J. 1999, 18:1905-1914.
21. Epstein A.C., Gleadle J.M., McNeill L.A., Hewitson K.S., O'Rourke J., Mole D.R., Mukherji M., Metzen E., Wilson M.I., Dhanda A., Tian Y.M., Masson N., Hamilton D.L., Jaakkola P., Barstead R., Hodgkin J., Maxwell P.H., Pugh C.W., Schofield C.J., Ratcliffe P.J. C. elegans EGL-9 and mammalian homologs define a family of dioxygenases that regulate HIF by prolyl hydroxylation. Cell 2001, 107:43-54.
22. Fitzgerald M.L., Xavier R., Haley K.J., Welti R., Goss J.L., Brown C.E., Zhuang D.Z., Bell S.A., Lu N., McKee M., Seed B., Freeman M.W. ABCA3 inactivation in mice causes respiratory failure, loss of pulmonary surfactant, and depletion of lung phosphatidylglycerol. J. Lipid Res. 2007, 48:621-632.
23. Fukuda R., Zhang H., Kim J.W., Shimoda L., Dang C.V., Semenza G.L. HIF-1 regulates cytochrome oxidase subunits to optimize efficiency of respiration in hypoxic cells. Cell 2007, 129:111-122.
24. Gao Y., Raj J.U. Regulation of the pulmonary circulation in the fetus and newborn. Physiol. Rev. 2010, 90:1291-1335.
25. Gardner L.B., Li Q., Park M.S., Flanagan W.M., Semenza G.L., Dang C.V. Hypoxia inhibits G1/S transition through regulation of p27 expression. J. Biol. Chem. 2001, 276:7919-7926.
26. Gassmann M., Kvietikova I., Rolfs A., Wenger R.H. Oxygen- and dioxin-regulated gene expression in mouse hepatoma cells. Kidney Int. 1997, 51:567-574.
27. Gebb S.A., Jones P.L. Hypoxia and lung branching morphogenesis. Adv. Exp. Med. Biol. 2003, 543:117-125.
28. Gebb S.A., Fox K., Vaughn J., McKean D., Jones P.L. Fetal oxygen tension promotes tenascin-C-dependent lung branching morphogenesis. Dev. Dyn. 2005, 234:1-10.
29. Goda N., Ryan H.E., Khadivi B., McNulty W., Rickert R.C., Johnson R.S. Hypoxia-inducible factor 1alpha is essential for cell cycle arrest during hypoxia. Mol. Cell. Biol. 2003, 23:359-369.
30. Gossen M., Bujard H. Tight control of gene expression in mammalian cells by tetracycline-responsive promoters. Proc. Natl. Acad. Sci. U. S. A. 1992, 89:5547-5551.
31. Green S.L., Freiberg R.A., Giaccia A.J. p21(Cip1) and p27(Kip1) regulate cell cycle reentry after hypoxic stress but are not necessary for hypoxia-induced arrest. Mol. Cell. Biol. 2001, 21:1196-1206.
32. Groenman F., Rutter M., Caniggia I., Tibboel D., Post M. Hypoxia-inducible factors in the first trimester human lung. J. Histochem. Cytochem. 2007, 55:355-363.
33. Grover T.R., Asikainen T.M., Kinsella J.P., Abman S.H., White C.W. Hypoxia-inducible factors HIF-1alpha and HIF-2alpha are decreased in an experimental model of severe respiratory distress syndrome in preterm lambs. Am. J. Physiol. Lung Cell. Mol. Physiol. 2007, 292:L1345-L1351.
34. Gustafsson M.V., Zheng X., Pereira T., Gradin K., Jin S., Lundkvist J., Ruas J.L., Poellinger L., Lendahl U., Bondesson M. Hypoxia requires notch signaling to maintain the undifferentiated cell state. Dev. Cell 2005, 9:617-628.
35. Hammel M., Michel G., Hoefer C., Klaften M., Muller-Hocker J., de Angelis M.H., Holzinger A. Targeted inactivation of the murine Abca3 gene leads to respiratory failure in newborns with defective lamellar bodies. Biochem. Biophys. Res. Commun. 2007, 359:947-951.
36. Hassid W.Z., Abraham S. Chemical procedures for analysis of polysaccharides. Methods Enzymol. 1957, 3:35-36.
37. Hogan B.L., Yingling J.M. Epithelial/mesenchymal interactions and branching morphogenesis of the lung. Curr. Opin. Genet. Dev. 1998, 8:481-486.
38. Huang L.E., Gu J., Schau M., Bunn H.F. Regulation of hypoxia-inducible factor 1alpha is mediated by an O2-dependent degradation domain via the ubiquitin-proteasome pathway. Proc. Natl. Acad. Sci. U. S. A. 1998, 95:7987-7992.
39. Hyatt B.A., Shangguan X., Shannon J.M. BMP4 modulates fibroblast growth factor-mediated induction of proximal and distal lung differentiation in mouse embryonic tracheal epithelium in mesenchyme-free culture. Dev. Dyn. 2002, 225:153-165.
40. Ivan M., Haberberger T., Gervasi D.C., Michelson K.S., Gunzler V., Kondo K., Yang H., Sorokina I., Conaway R.C., Conaway J.W., Kaelin W.G.J. Biochemical purification and pharmacological inhibition of a mammalian prolyl hydroxylase acting on hypoxia-inducible factor. Proc. Natl. Acad. Sci. U. S. A. 2002, 99:13459-13464.
41. Iyer N.V., Kotch L.E., Agani F., Leung S.W., Laughner E., Wenger R.H., Gassmann M., Gearhart J.D., Lawler A.M., Yu A.Y., Semenza G.L. Cellular and developmental control of O2 homeostasis by hypoxia-inducible factor 1 alpha. Genes Dev. 1998, 12:149-162.
42. Kaner R.J., Ladetto J.V., Singh R., Fukuda N., Matthay M.A., Crystal R.G. Lung overexpression of the vascular endothelial growth factor gene induces pulmonary edema. Am. J. Respir. Cell Mol. Biol. 2000, 22:657-664.
43. Karkkainen M.J., Haiko P., Sainio K., Partanen J., Taipale J., Petrova T.V., Jeltsch M., Jackson D.G., Talikka M., Rauvala H., Betsholtz C., Alitalo K. Vascular endothelial growth factor C is required for sprouting of the first lymphatic vessels from embryonic veins. Nat. Immunol. 2004, 5:74-80.
44. Koritzinsky M., Magagnin M.G., van den Beucken T., Seigneuric R., Savelkouls K., Dostie J., Pyronnet S., Kaufman R.J., Weppler S.A., Voncken J.W., Lambin P., Koumenis C., Sonenberg N., Wouters B.G. Gene expression during acute and prolonged hypoxia is regulated by distinct mechanisms of translational control. EMBO J. 2006, 25:1114-1125.
45. Koshiji M., Kageyama Y., Pete E.A., Horikawa I., Barrett J.C., Huang L.E. HIF-1alpha induces cell cycle arrest by functionally counteracting Myc. EMBO J. 2004, 23:1949-1956.
46. Lando D., Peet D.J., Gorman J.J., Whelan D.A., Whitelaw M.L., Bruick R.K. FIH-1 is an asparaginyl hydroxylase enzyme that regulates the transcriptional activity of hypoxia-inducible factor. Genes Dev. 2002, 16:1466-1471.
47. Lando D., Peet D.J., Whelan D.A., Gorman J.J., Whitelaw M.L. Asparagine hydroxylation of the HIF transactivation domain a hypoxic switch. Science 2002, 295:858-861.
48. Le Cras T.D., Spitzmiller R.E., Albertine K.H., Greenberg J.M., Whitsett J.A., Akeson A.L. VEGF causes pulmonary hemorrhage, hemosiderosis, and air space enlargement in neonatal mice. Am. J. Physiol. Lung Cell. Mol. Physiol. 2004, 287:L134-L142.
49. Lee Y.M., Jeong C.H., Koo S.Y., Son M.J., Song H.S., Bae S.K., Raleigh J.A., Chung H.Y., Yoo M.A., Kim K.W. Determination of hypoxic region by hypoxia marker in developing mouse embryos in vivo: a possible signal for vessel development. Dev. Dyn. 2001, 220:175-186.
50. Li Y., Zhang H., Xie M., Hu M., Ge S., Yang D., Wan Y., Yan B. Abundant expression of Dec1/stra13/sharp2 in colon carcinoma: its antagonizing role in serum deprivation-induced apoptosis and selective inhibition of procaspase activation. Biochem. J. 2002, 367:413-422.
51. Lohela M., Helotera H., Haiko P., Dumont D.J., Alitalo K. Transgenic induction of vascular endothelial growth factor-C is strongly angiogenic in mouse embryos but leads to persistent lymphatic hyperplasia in adult tissues. Am. J. Pathol. 2008, 173:1891-1901.
52. Mahon P.C., Hirota K., Semenza G.L. FIH-1: a novel protein that interacts with HIF-1alpha and VHL to mediate repression of HIF-1 transcriptional activity. Genes Dev. 2001, 15:2675-2686.
53. Mallory B.P., Mead T.J., Wiginton D.A., Kulkarni R.M., Greenberg J.M., Akeson A.L. Lymphangiogenesis in the developing lung promoted by VEGF-A. Microvasc. Res. 2006, 72:62-73.
54. Maltepe E., Schmidt J.V., Baunoch D., Bradfield C.A., Simon M.C. Abnormal angiogenesis and responses to glucose and oxygen deprivation in mice lacking the protein ARNT. Nature 1997, 386:403-407.
55. Mason R.J., Nellenbogen J., Clements J.A. Isolation of disaturated phosphatidylcholine with osmium tetroxide. J. Lipid Res. 1976, 17:281-284.
56. Moens C.B., Auerbach A.B., Conlon R.A., Joyner A.L., Rossant J. A targeted mutation reveals a role for N-myc in branching morphogenesis in the embryonic mouse lung. Genes Dev. 1992, 6:691-704.
57. Moens C.B., Stanton B.R., Parada L.F., Rossant J. Defects in heart and lung development in compound heterozygotes for two different targeted mutations at the N-myc locus. Development 1993, 119:485-499.
58. Morimoto M., Liu Z., Cheng H.T., Winters N., Bader D., Kopan R. Canonical Notch signaling in the developing lung is required for determination of arterial smooth muscle cells and selection of Clara versus ciliated cell fate. J. Cell Sci. 2010, 123:213-224.
59. Mukhopadhyay D., Tsiokas L., Sukhatme V.P. Wild-type p53 and v-Src exert opposing influences on human vascular endothelial growth factor gene expression. Cancer Res. 1995, 55:6161-6165.
60. Okubo T., Knoepfler P.S., Eisenman R.N., Hogan B.L. Nmyc plays an essential role during lung development as a dosage-sensitive regulator of progenitor cell proliferation and differentiation. Development 2005, 132:1363-1374.
61. Oladipupo S.S., Hu S., Santeford A.C., Yao J., Kovalski J.R., Shohet R.V., Maslov K., Wang L.V., Arbeit J.M. Conditional HIF-1 induction produces multistage neovascularization with stage-specific sensitivity to VEGFR inhibitors and myeloid cell independence. Blood 2011, 117:4142-4153.
62. Perl A.K., Zhang L., Whitsett J.A. Conditional expression of genes in the respiratory epithelium in transgenic mice: cautionary notes and toward building a better mouse trap. Am. J. Respir. Cell Mol. Biol. 2009, 40:1-3.
63. Rice W.R., Conkright J.J., Na C.L., Ikegami M., Shannon J.M., Weaver T.E. Maintenance of the mouse type II cell phenotype in vitro. Am. J. Physiol. Lung Cell. Mol. Physiol. 2002, 283:L256-L264.
64. Rocha S.F., Adams R.H. Molecular differentiation and specialization of vascular beds. Angiogenesis 2009, 12:139-147.
65. Ryan H.E., Lo J., Johnson R.S. HIF-1 alpha is required for solid tumor formation and embryonic vascularization. EMBO J. 1998, 17:3005-3015.
66. Sahlgren C., Gustafsson M.V., Jin S., Poellinger L., Lendahl U. Notch signaling mediates hypoxia-induced tumor cell migration and invasion. Proc. Natl. Acad. Sci. U. S. A. 2008, 105:6392-6397.
67. Saini Y., Harkema J.R., LaPres J.J. HIF1alpha is essential for normal intrauterine differentiation of alveolar epithelium and surfactant production in the newborn lung of mice. J. Biol. Chem. 2008, 283:33650-33657.
68. Sawai S., Shimono A., Wakamatsu Y., Palmes C., Hanaoka K., Kondoh H. Defects of embryonic organogenesis resulting from targeted disruption of the N-myc gene in the mouse. Development 1993, 117:1445-1455.
69. Schlaeger T.M., Bartunkova S., Lawitts J.A., Teichmann G., Risau W., Deutsch U., Sato T.N. Uniform vascular-endothelial-cell-specific gene expression in both embryonic and adult transgenic mice. Proc. Natl. Acad. Sci. U. S. A. 1997, 94:3058-3063.
70. Schofield C.J., Ratcliffe P.J. Oxygen sensing by HIF hydroxylases. Nat. Rev. Mol. Cell Biol. 2004, 5:343-354.
71. Scortegagna M., Ding K., Oktay Y., Gaur A., Thurmond F., Yan L.J., Marck B.T., Matsumoto A.M., Shelton J.M., Richardson J.A., Bennett M.J., Garcia J.A. Multiple organ pathology, metabolic abnormalities and impaired homeostasis of reactive oxygen species in Epas1-/- mice. Nat. Genet. 2003, 35:331-340.
72. Teles-Grilo M.L., Leite-Almeida H., Martins dos Santos J., Oliveira C., Boaventura P., Grande N.R. Differential expression of collagens type I and type IV in lymphangiogenesis during the angiogenic process associated with bleomycin-induced pulmonary fibrosis in rat. Lymphology 2005, 38:130-135.
73. Tzouvelekis A., Harokopos V., Paparountas T., Oikonomou N., Chatziioannou A., Vilaras G., Tsiambas E., Karameris A., Bouros D., Aidinis V. Comparative expression profiling in pulmonary fibrosis suggests a role of hypoxia-inducible factor-1alpha in disease pathogenesis. Am. J. Respir. Crit. Care Med. 2007, 176:1108-1119.
74. van Tuyl M., Liu J., Wang J., Kuliszewski M., Tibboel D., Post M. Role of oxygen and vascular development in epithelial branching morphogenesis of the developing mouse lung. Am. J. Physiol. Lung Cell. Mol. Physiol. 2005, 288:L167-L178.
75. Warburton D., Schwarz M., Tefft D., Flores-Delgado G., Anderson K.D., Cardoso W.V. The molecular basis of lung morphogenesis. Mech. Dev. 2000, 92:55-81.
76. Wenger R.H., Stiehl D.P., Camenisch G. Integration of oxygen signaling at the consensus HRE. Sci. STKE 2005, re12.
77. White A.C., Xu J., Yin Y., Smith C., Schmid G., Ornitz D.M. FGF9 and SHH signaling coordinate lung growth and development through regulation of distinct mesenchymal domains. Development 2006, 133:1507-1517.
78. Yamashita T., Ohneda O., Nagano M., Iemitsu M., Makino Y., Tanaka H., Miyauchi T., Goto K., Ohneda K., Fujii-Kuriyama Y., Poellinger L., Yamamoto M. Abnormal heart development and lung remodeling in mice lacking the hypoxia-inducible factor-related basic helix-loop-helix PAS protein NEPAS. Mol. Cell. Biol. 2008, 28:1285-1297.
79. Young R.M., Wang S.J., Gordan J.D., Ji X., Liebhaber S.A., Simon M.C. Hypoxia-mediated selective mRNA translation by an internal ribosome entry site-independent mechanism. J. Biol. Chem. 2008, 283:16309-16319.
80. Yu A.Y., Frid M.G., Shimoda L.A., Wiener C.M., Stenmark K., Semenza G.L. Temporal, spatial, and oxygen-regulated expression of hypoxia-inducible factor-1 in the lung. Am. J. Physiol. 1998, 275:L818-L826.
81. Yun Z., Maecker H.L., Johnson R.S., Giaccia A.J. Inhibition of PPAR gamma 2 gene expression by the HIF-1-regulated gene DEC1/Stra13: a mechanism for regulation of adipogenesis by hypoxia. Dev. Cell 2002, 2:331-341.
82. Zeng X., Wert S.E., Federici R., Peters K.G., Whitsett J.A. VEGF enhances pulmonary vasculogenesis and disrupts lung morphogenesis in vivo. Dev. Dyn. 1998, 211:215-227.
83. Zhang H., Gao P., Fukuda R., Kumar G., Krishnamachary B., Zeller K.I., Dang C.V., Semenza G.L. HIF-1 inhibits mitochondrial biogenesis and cellular respiration in VHL-deficient renal cell carcinoma by repression of C-MYC activity. Cancer Cell 2007, 11:407-420.
84. Zhang H., Bosch-Marce M., Shimoda L.A., Tan Y.S., Baek J.H., Wesley J.B., Gonzalez F.J., Semenza G.L. Mitochondrial autophagy is an HIF-1-dependent adaptive metabolic response to hypoxia. J. Biol. Chem. 2008, 283:10892-10903.